Results 91 to 100 of about 33,608 (178)

Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: report of an investigation. [PDF]

Lancet Microbe, 2023
Gould CV, Free RJ, Bhatnagar J, Soto RA, Royer TL, Maley WR, Moss S, Berk MA, Craig-Shapiro R, Kodiyanplakkal RPL, Westblade LF, Muthukumar T, Puius YA, Raina A, Hadi A, Gyure KA, Trief D, Pereira M, Kuehnert MJ, Ballen V, Kessler DA, Dailey K, Omura C, Doan T, Miller S, Wilson MR, Lehman JA, Ritter JM, Lee E, Silva-Flannery L, Reagan-Steiner S, Velez JO, Laven JJ, Fitzpatrick KA, Panella A, Davis EH, Hughes HR, Brault AC, St George K, Dean AB, Ackelsberg J, Basavaraju SV, Chiu CY, Staples JE, Yellow Fever Vaccine Virus Transplant and Transfusion Investigation Team.   +44 more
europepmc   +1 more source

A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine. [PDF]

NPJ Vaccines, 2022
Desai S, Anil K, Potey AV, Sindhu Y, Grappi S, Lapini G, Manney S, Tyagi P, Montomoli E, Poonawalla CS, Kulkarni PS.   +10 more
europepmc   +1 more source

Yellow Fever—More a Policy and Planning Problem than a Biological One

Emerging Infectious Diseases, 2016
Charles H. Calisher, John P. Woodall
doaj   +1 more source

Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA. [PDF]

J Travel Med, 2023
Rojas A, Hachey W, Kaur G, Korejwo J, Muhammad R.   +4 more
europepmc   +1 more source

Acceptance of yellow fever vaccine in the older traveller: a cohort study. [PDF]

Acta Biomed, 2021
Ferrara P, Masuet-Aumatell C, Ramon-Torrell JM.   +2 more
europepmc   +1 more source

Effectiveness of the Local Additional Risk Minimisation Measures for Yellow Fever Vaccine in the United Kingdom: A Survey of Healthcare Professionals and Vaccinees. [PDF]

Pharmacoepidemiol Drug Saf
Karimi L, Luguzis A, Pawar N, Dufournet M, Morelli F, Thollot Y, Guichard MC, Petti G, Li L.   +8 more
europepmc   +1 more source

Yellow fever vaccine protects mice against Zika virus infection. [PDF]

PLoS Negl Trop Dis, 2021
Vicente Santos AC, Guedes-da-Silva FH, Dumard CH, Ferreira VNS, da Costa IPS, Machado RA, Barros-Aragão FGQ, Neris RLS, Dos-Santos JS, Assunção-Miranda I, Figueiredo CP, Dias AA, Gomes AMO, de Matos Guedes HL, Oliveira AC, Silva JL.   +15 more
europepmc   +1 more source

Yellow Fever Vaccine-Associated Viscerotropic Disease: A Unique Case of Atraumatic Splenic Rupture. [PDF]

Case Rep Infect Dis
Nortey E, Bediako EM, Mould GK, Mills-Annoh A, Ekremet K, Kyei-Baffour P, Ekem A, Clarke JCA, Apaloo EFEK, Quartey-Papafio S.   +9 more
europepmc   +1 more source

Anterograde transneuronal tracing and genetic control with engineered yellow fever vaccine YFV-17D. [PDF]

Nat Methods, 2021
Li E, Guo J, Oh SJ, Luo Y, Oliveros HC, Du W, Arano R, Kim Y, Chen YT, Eitson J, Lin DT, Li Y, Roberts T, Schoggins JW, Xu W.   +14 more
europepmc   +1 more source

Influence of obesity on susceptibility to systemic symptoms and host responses to orthoflaviviral infection: a prospective observational study using yellow fever vaccine to simulate acute infection. [PDF]

EBioMedicine
Syenina A, Tham CYL, Tng DJH, Chew VSY, Yee JX, Leong YS, Hamis NZ, Tan HC, Joon HY, Chan JT, Yang Y, Cheung YB, Ong EZ, Low JG, Ooi EE.   +14 more
europepmc   +1 more source